Navigation Links
Provectus Pharmaceuticals, Inc.'s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Date:5/7/2012

NEW YORK, May 7, 2012 /PRNewswire/ -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, today announced that its May 3rd RetailInvestorConferences.com presentation is now available for on-demand viewing.

LINK: www.retailinvestorconferences.com > red "register/ watch event now" button

Provectus Pharmaceuticals, Inc's presentation will be available for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks.

About Provectus Pharmaceuticals Inc.

Provectus Pharmaceuticals (PVCT) specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. Its dermatological drug PH-10 also targets abnormal or diseased cells, with the current focus on psoriasis and atopic dermatitis. Provectus has recently completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis.

About RetailInvestorConferences.com

Since 2010, RetailInvestorConferences.com, created by BetterInvesting (NAIC) PR Newswire and MUNCmedia, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network and MUNCmedia's sophisticated retail investor targeting.

FORWARD-LOOKING STATEMENTS: The forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date thereof.


'/>"/>
SOURCE Provectus Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solta Medical Receives Provectus Innovation Award at MDB Capital Groups Bright Lights Intellectual Property Conference
2. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
3. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
4. Avion Pharmaceuticals, LLC Names Michael Sullivan as new VP, Sales and Marketing
5. Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim®
6. Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™
7. Optimer Pharmaceuticals, Inc. Announces Presentation at ECCMID of Post-Hoc Subgroup Analysis of DIFICID in Adult Cancer Patients Being Treated for Clostridium difficile-Associated Diarrhea (CDAD)
8. Gamma Pharmaceuticals, Inc. Announces Key Appointment in Sales and Marketing
9. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results
10. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year-End 2011 Financial Results
11. Tibet Pharmaceuticals, Inc. Announces Intent to Go Private
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... , ... October 10, 2019 , ... ... Gala Cocktail Reception on Thursday, September 26, at the Westchester Country Club in ... the unwavering support of the organization and its mission. , “In Celebration” featured ...
(Date:10/8/2019)... (PRWEB) , ... October 09, 2019 , ... “When Seconds ... emotions, frustrations, and the realities of the HEMS world through telling the real stories ... Pilot” is the creation of published author Jay A. Humphrey, an EMS helicopter pilot. ...
(Date:10/8/2019)... ... October 08, 2019 , ... Respected dentist, Dr. Kenneth ... to enhance his skill and knowledge of dental implant diagnosis, placement and maintenance. ... four-part series of classes that combines in-depth lectures with hands-on workshops. Halfway through ...
Breaking Medicine Technology:
(Date:10/11/2019)... ... ... A Topping Out event was hosted today at the construction site of the Southwest ... event celebrated reaching the final height of the structure set to open in the ... in Texas, STA’s facility will be home to an organ recovery center including a ...
(Date:10/10/2019)... ... October 10, 2019 , ... Santa ... (IT) services for the healthcare industry, has completed the first phase of a ... the Commonwealth of The Bahamas towards a fully integrated health information management system ...
(Date:10/10/2019)... ... October 10, 2019 , ... In ... 21 was excited to hear the significant results of an independent study presented ... of Nitrosigine®. The clinical study poster entitled “The Acute Effects of Citrulline Malate ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... What unique ... and future state of aging and wellness in the nation? That question will be ... Active Aging Conference, Leadership Summit and Expo. The event will take place October 10-12, ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... majority interest in Advanced Fertility Care (AFC), an advanced reproductive services (RE) facility ... expand the availability of RE services to expectant families throughout Arizona and the ...
Breaking Medicine News(10 mins):